**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 75-09-2 |Dichloromethane | | 200-838-9
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Limited evidence of a carcinogenic effect.
Potential Health Effects
Eye:
Contact with eyes may cause severe irritation, and possible eye
burns.
Skin:
May be absorbed through the skin. Causes irritation with burning
pain, itching, and redness. Prolonged exposure may result in skin
burns.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause kidney damage. May cause central nervous system
depression, characterized by excitement, followed by headache,
dizziness, drowsiness, and nausea. Advanced stages may cause
collapse, unconsciousness, coma and possible death due to
respiratory failure. May cause carboxyhemoglobinemia.
Inhalation:
Inhalation of high concentrations may cause central nervous system
effects characterized by nausea, headache, dizziness, unconsciousness
and coma. Causes respiratory tract irritation. May cause narcotic
effects in high concentration. Vapors may cause dizziness or
suffocation. May cause blood changes. Overexposure may cause an
increase in carboxyhemoglobin levels in the blood. Can produce
delayed pulmonary edema.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Prolonged or repeated skin contact may cause dermatitis. May cause
reproductive and fetal effects. Laboratory experiments have resulted
in mutagenic effects. Chronic exposure may cause lung, liver, and
pancreatic tumors. May cause conjunctivitis and/or corneal burns.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove
contaminated clothing and shoes. Get medical aid if irritation
develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Use water spray to keep fire-exposed containers
cool. No flash point in conventional closed tester, but forms
flammable vapor-air mixtures in larger volumes and may be an
explosion hazard in a confined space.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Avoid contact with eyes, skin, and clothing. Keep
container tightly closed. Avoid contact with heat, sparks and flame.
Use only with adequate ventilation. Avoid breathing vapor or mist.
Storage:
Store in a tightly closed container. Keep from contact with
oxidizing materials. Store in a cool, dry, well-ventilated area away
from incompatible substances. Store below 40C. Keep away from active
metals.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Personal Protective Equipment
Eyes:
Wear chemical goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant a respirator's use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless liquid
Odor: ethereal odor - chloroform-like
pH: Not available.
Vapor Pressure: 350 mm Hg @ 20 deg C
Viscosity: Not available.
Boiling Point: 40 deg C
Freezing/Melting Point: -97 deg C
Autoignition Temperature: 556 deg C ( 1,032.80 deg F)
Flash Point: Not applicable.
Explosion Limits, lower: 13 vol %
Explosion Limits, upper: 23 vol %
Decomposition Temperature: Not available.
Solubility in water: Slightly soluble.
Specific Gravity/Density: 1.33 (Water=1)
Molecular Formula: CH2Cl2
Molecular Weight: 84.92
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions. May form explosive mixtures in atmospheres
having high oxygen content.
Conditions to Avoid:
Excess heat, attacks some plastics, rubber, and coatings, confined
spaces.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases, chemically active metals.
Hazardous Decomposition Products:
Hydrogen chloride, phosgene, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 75-09-2: PA8050000
LD50/LC50:
CAS# 75-09-2: Draize test, rabbit, eye: 162 mg Moderate; Draize
test, rabbit, eye: 10 mg Mild; Draize test, rabbit, eye: 500 mg/24H
Mild; Draize test, rabbit, skin: 810 mg/24H Severe; Draize test,
rabbit, skin: 100 mg/24H Moderate; Inhalation, mouse: LC50 = 14400
ppm/7H; Inhalation, rat: LC50 = 52 gm/m3; Oral, mouse: LD50 = 873
mg/kg; Oral, rat: LD50 = 1600 mg/kg.
Carcinogenicity:
Dichloromethane -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Ecotoxicity:
Fish: Bluegill/Sunfish: 230mg/L; 24H; StaticFish: Fathead Minnow:
196mg/L; 96HThis chemical has a moderate potential to affect some
aquatic organisms. It is resistant to biodegradation, and has a low
potential to persist in the aquatic environment. 96-hr. EC50 (loss of
equilibrium); Fathead minnow: 99mg/L; 96-hr. EC10: 66.3 mg/L.
Bluegill sunfish: 96-hr. LC50=220 mg/L; Water flea: 24-hr. LC50=2270
mg/L; No observed effect level:1550 mg/L.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: DICHLOROMETHANE
Hazard Class: 6.1
UN Number: 1593
Packing Group: III
IMO
Shipping Name: DICHLOROMETHANE
Hazard Class: 6.1
UN Number: 1593
Packing Group: III
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 24/25 Avoid contact with skin and eyes.
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 75-09-2: 2
United Kingdom Occupational Exposure Limits
United Kingdom Maximum Exposure Limits
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 75-09-2 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 75-09-2: OEL-AUSTRALIA:TWA 100 ppm (350 mg/m3);Carcinogen
OEL-AUSTRIA:TWA 100 ppm (360 mg/m3)
OEL-BELGIUM:TWA 50 ppm (174 mg/m3);Carcinogen
OEL-CZECHOSLOVAKIA:TWA 500 mg/m3;STEL 2500 mg/m3
OEL-DENMARK:TWA 50 ppm (175 mg/m3);Skin;Carcinoge
OEL-FINLAND:TWA 100 ppm (350 mg/m3);STEL 250 ppm (870 mg/m3)
OEL-FRANCE:TWA 100 ppm (360 mg/m3);STEL 500 ppm (1800 mg/m3)
OEL-GERMANY:TWA 100 ppm (360 mg/m3);Carcinogen
OEL-HUNGARY:STEL 10 mg/m3;Carcinogen
OEL-JAPAN:TWA 100 ppm (350 mg/m3)
OEL-THE NETHERLANDS:TWA 100 ppm (350 mg/m3);STEL 500 ppm
OEL-THE PHILIPINES:TWA 500 ppm (1740 mg/m3)
OEL-POLAND:TWA 50 mg/m3
OEL-RUSSIA:TWA 100 ppm;STEL 50 mg/m3
OEL-SWEDEN:TWA 35 ppm (120 mg/m3);STEL 70 ppm (25 mg/m3);Skin
OEL-SWITZERLAND:TWA 100 ppm (360 mg/m3);STEL 500 ppm
OEL-THAILAND:TWA 500 mg/m3;STEL 1000 mg/m3
OEL-TURKEY:TWA 500 ppm (1740 mg/m3)
OEL-UNITED KINGDOM:TWA 100 ppm (350 mg/m3);STEL 250 ppm
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGI TLV
US FEDERAL
TSCA
CAS# 75-09-2 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 1/16/2002 Revision #2 Date: 6/24/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-(3,4-Dimethoxyphenyl)-Ethylamine, 98%
| 120-20-7 |
|
2-Bromo-9-Fluorenone, 95%
| 3096-56-8 |
|
Potassium trihydrogen dioxalate dihydrate, 99%
| 6100-20-5 |
|
2-Chloromethyl-5-(4-Methoxyphenyl)-1,2,4-Oxadiazole, 98%
| 24023-71-0 |
|
2-Chloromethyl-5-(4-Chlorophenyl)-1,2,4-Oxadiazole, 98%
| 24068-15-3 |
|
Tetramethylgermanium, 97%
| 865-52-1 |
|
Phenyltosylate
| 640-60-8 |
|
Tetra-n-butylammonium hexafluorophosphate, 98%
| 3109-63-5 |
|
4-Methyl-2-nitrophenol, 99%
| 119-33-5 |
|
Tetraphenylgermanium, 97%
| 1048-05-1 |
|
2,3-Dibromopropionic Acid, 99%
| 600-05-5 |
|
Magnesium trifluoromethanesulfonate, 98%
| 60871-83-2 |
|
Tetraethyl orthocarbonate, 97%
| 78-09-1 |
|
N-(8-Bromooctyl)phthalimide
| 17702-83-9 |
|
4-Chloro-2-nitrophenol, 98%
| 89-64-5 |
|
cis-N-(4-Chlorobutenyl)Phthalimide, 97%
| 84347-67-1 |
|
4-Fluoro-o-xylene, 98%
| 452-64-2 |
|
2-Phenylglutaric anhydride, 97%
| 2959-96-8 |
|
Methyl tiglate, 98%
| 6622-76-0 |
|
Lobeline sulfate, 99%
| 134-64-5 |
|
Methyl triphenylarsonium iodide, 98%
| 1499-33-8 |
|
Hexa-n-butylditin, 98%
| 813-19-4 |
|
Hydrocortisone, 98%
| 50-23-7 |
|
Benzylurea, 93%
| 538-32-9 |
|
Dichloromethane, peptide synthesis grade, stabilized
| 75-09-2 |
|
N,N-Dicyclohexylcarbodiimide, 0.1M solution in dichloromethane,
| 75-09-2 |
|
N,N'-Dicyclohexylcarbodiimide, 1M solution in N-methylpyrrolidone,
| 538-75-0 |
|
N,N-Dimethylformamide, peptide synthesis grade
| 68-12-2 |
|
1,1,1,3,3,3-Hexafluoro-2-propanol, peptide synthesis grade
| 920-66-1 |
|
alpha,alpha,alpha',alpha',-Tetrachloro-p-xylene
| 7398-82-5 |
|
Bromine Water
| 7726-95-6 |
|
1,1,1,3,3,3-Hexafluoro-2-propanol, 10% in dichloromethane, peptide
| 75-09-2 |
|
1-Methyl-2-pyrrolidone, special automatic peptide synthesizer grade
| 872-50-4 |
|
N-Methylpyrrolidone, peptide synthesis grade
| 872-50-4 |
|
Methylsulfoxide, peptide synthesis grade
| 67-68-5 |
|
Ferrocene, 98%
| 102-54-5 |
|
1,2-Diiodotetrafluoroethane, 98%
| 354-65-4 |
|
5-Chlorothiophene-2-carboxylic acid, 98%
| 24065-33-6 |
|
trans-4-Methoxycinnamaldehyde, 98%
| 24680-50-0 |
|
trans-2-Methyl-2-butenal
| 497-03-0 |
|
Ethyl 3-phenylpropionate, 98%
| 2021-28-5 |
|
Allyl chloroformate, 97%
| 2937-50-0 |
|
2-Amino-3,3-dimethylbutane, 98%
| 3850-30-4 |
|
4-Tert-Butylbenzonitrile, 98%
| 4210-32-6 |
|
3-Aminopropionitrile, stabilized, 98%
| 151-18-8 |
|
4-Chlorophenylsulfonylacetonitrile, 98%
| 1851-09-8 |
|
p-Toluenesulfonylacetonitrile, 98%
| 5697-44-9 |
|
Methyl thiophene-2-carboxylate, 98%
| 5380-42-7 |
|
n-Amylbenzoate, 98%
| 2049-96-9 |
|
Isosorbide, 98%
| 652-67-5 |
|
|